5 TSX health stocks to buy as COVID and monkeypox cases spike in Canada

By - Kajal Jain


  • BHC stock shot up by nearly 12 per cent in one month
  • BLU stock galloped by over 247 per cent year-over-year
  • HLS is set to deliver a quarterly dividend of C$ 0.05 on September 15

Some Canadian provinces are reportedly witnessing a major surge in COVID infections, signalling the seventh wave that could peak in Canada in the coming weeks.

According to the Public Health Ontario (PHO), COVID outbreaks in high-risk settings grew by 87 per cent on a weekly basis from July 3 to July 9. The latest data shows that long-term care homes saw 42 outbreaks this week, representing a 110 per cent increase from 20 outbreaks reported in the previous week. 

In addition, Canada is also seeing rising monkeypox cases, with Ontario reporting 194 confirmed cases as of July 14.

Amid these health challenges, investors seem to be turning toward healthcare stocks like Bausch Health (TSX: BHC), BELLUS Health (TSX: BLU), Well (TSX: WELL) etc., so let's look at five TSX health stocks closely.

Open in the App